NEWS RELEASE
FOR IMMEDIATE RELEASE
January 5,
2005
Contacts:
FEMINISTS TO
COMMIT CIVIL DISOBEDIENCE AT FDA TO GET MORNING-AFTER PILL OVER THE
COUNTER
WHAT: A
press conference and Speakout, where women will break the law by
handing out
the Morning-After Pill (MAP) in defiance of the unnecessary
prescription
requirement on the Morning-After Pill (MAP).
PARTICIPANTS:
The
Morning-After Pill Conspiracy, a national coalition of feminist
organizations who
support this event, including the Women's Liberation Birth-Control
Project (formerly New York NOW Reproductive Rights Task
Force);
Redstockings Allies and Veterans, NYC; Gainesville Area (FL) National
Organization for Women (NOW); Florida NOW Young Feminist Task Force;
Gainesville (FL) Women’s Liberation; the
state organizations of Florida NOW and California NOW; and the U.S.
Congresswoman Carolyn Maloney’s office.
WHERE: The
Food and Drug Administration, 5600 Fishers Lane Rockville, Maryland.
Sidewalk
in front of the main entrance. Within walking distance of Twinbrook
Metro
Station.
WHEN: Friday,
January 7th, 12 noon
The Food and Drug Administration (FDA) is
slated to
make a decision on over-the-counter (OTC) status for the Morning-After
Pill
(brand name Plan BTM) by January 22, 2005.
On Friday, January 7th,
women will converge on the steps of the FDA to demand OTC status and
protest
the year-long delay in the approval process.
We will register our protest by handing out the Morning-After
Pill (MAP)
to any woman who wants it, in defiance of the FDA’s medically
unnecessary
prescription requirement. We will
be joined by Kim Gandy, President of the National Organization for
Women. Women will speak out to the FDA and
the
public from our own experiences about using the MAP or not being able
to get it
in time, due to the expense and long delays caused by the prescription
requirement.
We are not alone in demanding
over-the-counter
status (OTC) for the Morning-After Pill. On Dec. 16, 2003, two FDA
advisory
committees voted overwhelmingly (23-4) to recommend that the FDA
eliminate the
prescription requirement and grant OTC status to the MAP.
More than 70 health groups, including the
American Medical Association and the American College of Obstetricians
and
Gynecologists, say it is safe for over-the-counter distribution. More than 60 U.S. newspapers have taken an
editorial position in support of over-the-counter access.
In more than 38 countries, women can walk
into a
store and get the MAP without a prescription—yet women in this country
have to jump through hoops to get it.
Due to White House pressure, the FDA has
dragged its
feet in making this decision since February 2004. In
May 2004, FDA representative Steven K. Galson announced the
FDA would delay its decision yet again, claiming there were not enough
studies
to prove the drug is safe for girls under 16 years old. Barr
Laboratories, the
makers of Plan BTM, was forced to submit a supplemental
application
to the FDA, requesting OTC status for women 16 and older, while the
prescription requirement would remain in effect for girls younger than
16. Not
only have studies
shown an age restriction to
be medically unnecessary, but all females would be impacted by this
decision—all
women will be required to produce an I.D. to prove our age. (See today’s issue of
Journal of American Medical Association, Jan.
5, 2005,
for an additional, new study citing no health risks to girls under 16
who have
access to the MAP; cite USA Today, 1/5/05, p. 6D.)
Rather than the MAP being
on the drugstore shelf
next to shampoo, an age restriction would render it “behind the
counter,” a
restrictive status only in effect in the United States for
smoking-cessation
drugs.
Background:
In support of today’s Speakout, New York Congresswoman Carolyn Maloney said, "Last summer, American women watched in horror as the FDA let politics trump science, going against the judgment of their own panel and deciding that emergency contraception should not be made over-the-counter. Members of Congress heard from scientists across the country, urging them to only accept scientific, evidence-based decisions that are in the best interest of the American public and that will help improve our health. As we wait for the FDA's upcoming decision, it is my hope that ideology will no longer be allowed to impact the health and well-being of thousands of American women."
“George Bush may be president for four more years, but we will not wait four years for advances for women,” said Erin Mahoney, Chair, Women's Liberation Birth-Control Project. “Democrat or Republican--if you do not do what is best for women, you will see us in the streets.”
* * * * *
Return to MAP Conspiracy Homepage